Across TCGA pan-cancer cohorts, MIR1238 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR1238 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR1238 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR1238 expression acts as an unfavorable survival marker.

KIRP, COAD, and TGCT are the cancer types where MIR1238 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	III,IV	0.127	0.811	<.001	72	view →
COAD	OS	Tertile	All	0.157	0.870	<.001	54	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	54	view →
SKCM	DFS	Tertile	III,IV	0.174	0.516	.002	42	view →
KIRC	OS	Tertile	All	0.584	0.884	<.001	30	view →
BLCA	DFS	Tertile	All	0.166	0.519	.029	27	view →
LUSC	OS	Tertile	All	0.003	0.819	<.001	18	view →
UCEC	OS	Tertile	IV	0.231	0.592	.036	18	view →
GBM	DFS	Tertile	All	0.061	0.288	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

Exploration

Same gene, other analysis: MIR1238 tumor-vs-normal RNA expression · all MIR1238 data types